Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07830563 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Evaluating the Safety and Effects of AMP-101 in People With DOK7 Congenital Myasthenia Syndrome

StatusNot Yet Recruiting
PhasePhase 1
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
This study is evaluating the safety and potential effects of AMP-101 in people with DOK7 Congenital Myasthenia Syndrome (CMS). Participants will receive a single dose of the study treatment and will be monitored to assess their health and response to treatment. Approximately 4 participants are expected to take part in the study.
Trial Details
NCT Number NCT07830563
Lead Sponsor Amplo Biotechnology
Conditions
(from sponsor)		 Congenital Myasthenia Syndrome
Related terms Myasthenic Syndromes, Congenital
Enrollment 4 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov